Related Experiment Video
Updated: Jan 8, 2026

Therapeutic Effectiveness of a Dietary Supplement for Management of Halitosis in Dogs
Published on: July 6, 2015
Harnessing Moringa oleifera Lam's Isothiocyanates for Targeted H2S Delivery: A Systematic Review of the Literature
Maria Ponticelli1,2, Rosangela Montanaro1, Vincenzo Calderone3,4,5
1Department of Health Science, University of Basilicata, Potenza, Italy.
Abstract:
The gasotransmitter hydrogen sulfide (H2S) and its natural donor isothiocyanates have been suggested by emerging evidence to play a significant role in the therapeutic management of several conditions like metabolic syndrome, neurodegeneration, inflammation, and so forth. In particular, isothiocyanates from Moringa oleifera Lam have been found to be more stable than those from cruciferous vegetables and Alliaceae, although they are less studied. For this reason, the present review aims to conduct a systematic literature search to outline the potential clinical applications of isothiocyanates, as a source of H2S, formed from glucosinolates present in M. oleifera. The systematic search was performed on Scopus and PubMed using wide-ranging keywords such as "Isothiocyanates" and "Moringa," "Isothiocyanates," and "Moringin," and "Moringin" alone. The selection was limited to publications written in English. All articles containing information on the biological activity of M. oleifera's isothiocyanates were considered for selecting articles for analysis. Review articles, letters, book chapters, editorials, conference papers, systematic reviews, and short surveys were not considered. This allowed the selection of 42 papers, which were analyzed per pathologies and evaluated for the risk of biases using the QUIN tool. Hence, this review gives an overview of the potential health benefits linked to M. oleifera's isothiocyanates as a natural source of H2S.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

